Table 2 Univariable regression of pre-operative demographics with pre-operative serum VCAM-1 concentration
Coefficient | Standard Error | r^2 | p-value | |
|---|---|---|---|---|
Gender (M/F) | 38.6 | 88.4 | 0.007 | 0.666 |
Age (yrs) | 3.83 | 3.68 | 0.047 | 0.310 |
BMI (kg/m2) | −0.16 | 9.56 | 0.000 | 0.987 |
Height (m) | 215.5 | 350.0 | 0.018 | 0.545 |
Weight (kg) | 3.48 | 3.77 | 0.037 | 0.366 |
MI | −26.3 | 90.7 | 0.003 | 0.774 |
PVD | −87.9 | 159.3 | 0.011 | 0.586 |
Stroke | 288.3 | 215.5 | 0.062 | 0.192 |
Hypertension | 61.9 | 90.1 | 0.017 | 0.498 |
Hypercholesterolaemia | 154.8 | 130.0 | 0.050 | 0.244 |
Family History | −40.77 | 66.9 | 0.014 | 0.547 |
Diabetes - On Insulin | 113.0 19.3 | 78.3 90.8 | 0.072 0.002 | 0.160 0.833 |
Smoking | −203.4 | 100.1 | 0.133 | 0.052 |
Alcohol >10u per week | −94.8 | 60.76 | 0.086 | 0.131 |
White cell count | −22.8 | 40.4 | 0.038 | 0.588 |
Platelet count | −2.24 | 1.67 | 0.182 | 0.218 |
C-reactive protein | 24.6 | 23.3 | 0.537 | 0.483 |
Beta-blocker use | −54.4 | 111.7 | 0.012 | 0.632 |
Statin use | 82.8 | 229.8 | 0.007 | 0.723 |
ACE-i | 70.5 | 104.7 | 0.023 | 0.509 |
Post-op medications | ||||
Beta-blocker use | −125.9 | 87.19 | 0.077 | 0.161 |
Statin use | 147.0 | 128.5 | 0.050 | 0.264 |
ACE-i | 138.1 | 83.45 | 0.099 | 0.110 |